Scopia Capital Management L.P., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 307,716 shares at $16.49 ($5.3M) on 2018-10-09, disclosed to the SEC on 2018-10-09.
Open-market sale of $5.3M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.51 | 37,526 | $657K | 12.4% |
| 2 | $17.51 | 37,526 | $657K | 12.4% |
| 3 | $17.87 | 60,042 | $1.1M | 20.2% |
| 4 | $17.87 | 60,042 | $1.1M | 20.2% |
| 5 | $16.49 | 56,290 | $928K | 17.5% |
| 6 | $16.49 | 56,290 |
| $928K |
| 17.5% |
| Total | $17.28 avg | 307,716 | $5.3M | 100% |
| Filing → |
| ITRI | SELL | 2019-05-03 | $7.4M | — | Filing → |
| ITRI | SELL | 2019-05-01 | $4.4M | — | Filing → |
| ITRI | SELL | 2019-04-22 | $1.4M | — | Filing → |